Ipsen loses another legal fight over biologic classification; Viking announces plan to bring injectable GLP-1 into Phase 3 study sooner; GE HealthCare makes moves with Amazon Web Services to develop Generative AI services.
Sanofi raises profit guidance following 10.2% sales growth in Q2
What does Google’s third-party cookie decision mean for medical marketers? CVS Caremark agrees to $45 million settlement with Illinois; Gilead’s twice-yearly shots used to treat HIV show 100% efficacy in women.
Pfizer CMO Drew Panayiotou to leave company, will be replaced by Susan Rienow